Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF V600E by synergistically decreasing global trimethylation of H3K27-Reference-Cited by-同舟云学术

Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF V600E by synergistically decreasing global trimethylation of H3K27

Published:2020-03 Issue:6 Volume:24 Page:3336-3345
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Fu Hao¹,Cheng Lin¹,Sa Ri¹,Jin Yuchen¹,Chen Libo¹^ORCID

Affiliation:

1. Department of Nuclear Medicine Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15007

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics in China, 2015

3. Biologic and Clinical Perspectives on Thyroid Cancer

4. Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation

5. Iodide- and Glucose-Handling Gene Expression Regulated by Sorafenib or Cabozantinib in Papillary Thyroid Cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Changes Induced by Infectious Agents in Cancer;Pathogens Associated with the Development of Cancer in Humans;2024

2. A clinically useful and biologically informative genomic classifier for papillary thyroid cancer;Frontiers in Endocrinology;2023-09-12

3. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective;Experimental & Molecular Medicine;2023-07-03

4. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy;Drug Resistance Updates;2023-05

5. Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer;International Journal of Molecular Sciences;2023-04-26